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The article by Tola et al provides critical insights into the 
psychosocial and patient perception aspects which predict treatment 
non-adherence in Tuberculosis (TB) patients on DOTS therapy (1). I 
would like to share certain additional perspectives which could be 
inferred from the findings of the study and may also be explored 
during future research on the subject.  
1. The application of Health Belief Model (HBM) in TB patients on 
antitubercular drug therapy (ATT) generates the hypothesis that 
those patients who perceive themselves to be susceptible to adverse 
health outcomes on medication non-adherence are more likely to be 
adherent. Moreover, TB is the most common opportunistic infection 
in HIV-AIDS and also the most likely cause of mortality in PLHIV 
(2). From the theoretical perspective of HBM, HIV-AIDS patients 
who develop TB and are initiated on ATT should perceive greater 
susceptibility and threat arising from risk of complications, hospital 
admissions and mortality when non-adherent to ATT. However, in 
this study, Tola et al found that TB patients on antiretroviral 
treatment (ART) were more likely to be non-adherent to ATT 
compared to non-HIV TB patients (Table 3). This suggests that 
perceived barriers to ATT therapy (like fear of adverse effects) were 
more likely to overwhelm patient perceptions regarding the severity 
of TB illness in those with HIV-TB coinfection. The design and 
application of focused and targeted interventions which enhance 
understanding of the adverse implications of non-adherence to ATT 
in HIV-TB patients is thereby required.  
2. TB patients may lapse into non-adherence or discontinue therapy 
(lost to follow-up) after the initial few weeks of ATT initiation. This 
occurs as patients perceive lesser susceptibility and lack of benefits 
from continuing therapy for the recommended duration. However, in 
this study, the duration of ATT in the participants was not factored as 
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